For the first time, heparin was incorporated into the country, which ushered in a change in the ten-billion market 2023-03-01
Asia Hong Pharma announced that it has co-developed an innovative tumor therapy based on AI+RNA technology route with ReviR 2023-02-16
Dapagliflozin is approved in the EU for the treatment of symptomatic chronic heart failure 2023-02-16
Tronsound long-acting IL-36R antibody obtained FDA clinical IND 2023-02-16
Hua Quejing Medical has received tens of millions of yuan of exclusive investment from Shenzhen Venture Capital continues to lead the intelligent development of rehabilitation robots 2023-02-10
Eli Lilly Tirzepatides Phase III trial in obese or overweight adult patients in China was successful 2023-02-10
Is the class solidified? From Biotech to Pharma 2023-02-10
Ribo Biologics announced that the worlds first FIH application for a siRNA drug targeting FXI has been successfully approved by HREC in Australia 2023-02-10
Asia Hong Pharma announced that it has co-developed an innovative tumor therapy based on AI+RNA technology route with ReviR 2023-02-10
Dapagliflozin is approved in the EU for the treatment of symptomatic chronic heart failure 2023-02-10
Tronsound long-acting IL-36R antibody obtained FDA clinical IND 2023-02-10
9 million people develop diabetes, which is strongly associated with this risk factor! 2023-01-12
Luoqi Biotech LQ043H single-domain antibody nebulizer was approved for clinical trials 2023-01-12
When the most prevalent mutant strain in the United States, it was detected in China 2023-01-12
2022 FDA approval of new drug transcript 2023-01-12
Qilu Pharmaceuticals "Ertapeneem Sodium for Injection" was approved for marketing the first to pass the consistency evaluation 2023-01-12
The State Food Drug Administration accepted the marketing application of Ditze Pharma suvortinib 2023-01-12
The global number of new crown sequelae is estimated to be nearly 145 million, we must be vigilant against these "new crown sequelae" after "Yangkang"! 2023-01-06
Nicolas Pharmaceutical, the life death bureau of innovative drug patents 2023-01-06
Domestic anti-HIV new drug, Addison Pharmaceuticals "Inomitine Tablets" was approved for marketing! 2023-01-06
Medical insurance negotiation prospect: sky-high drugs, Paxlovid waiting for "turning positive", PD-(L)1 once again chasing the deer... 2023-01-06
Deqi Pharmaceutical Merck reached a global clinical cooperation 2022-12-29
Clovis files for bankruptcy! The market value once exceeded 10 billion, PARP inhibitors once called AstraZeneca 2022-12-15
Lilly gave up the overseas rights interests of Cindilimab, Cinda PD-1 had difficulty going to sea? 2022-12-12
Global Vaccine Market Rises to the TopAgain 2022-11-17
The first in the world! Huadong Pharmaceuticals new FRα target ADC was approved by the FDA 2022-11-17
he worlds first! RSV prevention therapy for infants young children was approved, the tens of billions of market ushered in a competitive battle 2022-11-17
Fastest times="32" billion ADC drug? Who can fight Enhertu for Breast cancer? 2022-11-09
Pfizers paxlovid reduces the risk of COVID-19 by 26% 2022-11-09
The battle between Pfizer Gilead over COVID-19 drugs will continue 2022-11-04
1200 cases were newly prescribed by Junshi Biologic for mild to moderate disease 2022-11-02
With a $10 billion market a clinical shortage, the first "Snoring medicine" is expected to hit the market 2022-11-02
共
1510 个 页次:
3 /
48 页
32 个/页
首页 上一页 下一页 尾页
转到：
第1页
第2页
第3页
第4页
第5页
第6页
第7页
第8页
第9页
第10页
第11页
第12页
第13页
第14页
第15页
第16页
第17页
第18页
第19页
第20页
第21页
第22页
第23页
第24页
第25页
第26页
第27页
第28页
第29页
第30页
第31页
第32页
第33页
第34页
第35页
第36页
第37页
第38页
第39页
第40页
第41页
第42页
第43页
第44页
第45页
第46页
第47页
第48页
Our Advantages of Reports
①All reports written by ourselves
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
News 
